These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38296701)

  • 1. Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection.
    Huang Y; Shi H; Forgacs D; Ross TM
    Vaccine; 2024 Feb; 42(5):1184-1192. PubMed ID: 38296701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    Dulin H; Barre RS; Xu D; Neal A; Vizcarra E; Chavez J; Ulu A; Yang M-S; Khan SR; Wuang K; Bhakta N; Chea C; Wilson EH; Martinez-Sobrido L; Hai R
    J Virol; 2024 Feb; 98(2):e0157123. PubMed ID: 38206036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus.
    Wang Z; Li Z; Shi W; Zhu D; Hu S; Dinh PC; Cheng K
    Sci Adv; 2023 Jun; 9(25):eabo4100. PubMed ID: 37352360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    Chaparian RR; Harding AT; Hamele CE; Riebe K; Karlsson A; Sempowski GD; Heaton NS; Heaton BE
    J Virol; 2022 Aug; 96(15):e0068922. PubMed ID: 35862698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
    Handabile C; Ohno M; Sekiya T; Nomura N; Kawakita T; Kawahara M; Endo M; Nishimura T; Okumura M; Toba S; Sasaki M; Orba Y; Chua BY; Rowntree LC; Nguyen THO; Shingai M; Sato A; Sawa H; Ogasawara K; Kedzierska K; Kida H
    Sci Rep; 2024 Feb; 14(1):4204. PubMed ID: 38378856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge.
    Hill-Batorski L; Bowen R; Bielefeldt-Ohmann H; Moser MJ; Matejka SM; Marshall D; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2024 Apr; 42(11):2770-2780. PubMed ID: 38508930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine.
    Zhao D; Chen X; Wang L; Zhang J; Zhao Z; Yue N; Zhu Y; Fei W; Li X; Tan L; He W
    Int J Biol Macromol; 2023 Apr; 234():123635. PubMed ID: 36801224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters.
    Deng S; Liu Y; Tam RC; Chen P; Zhang AJ; Mok BW; Long T; Kukic A; Zhou R; Xu H; Song W; Chan JF; To KK; Chen Z; Yuen KY; Wang P; Chen H
    Nat Commun; 2023 Apr; 14(1):2081. PubMed ID: 37045873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
    Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
    mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies.
    Abd Alhadi M; Friedman LM; Karlsson EA; Cohen-Lavi L; Burkovitz A; Schultz-Cherry S; Noah TL; Weir SS; Shulman LM; Beck MA; Hertz T
    Microbiol Spectr; 2023 Jun; 11(3):e0001023. PubMed ID: 37098954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD.
    Li Y; Liu P; Hao T; Liu S; Wang X; Xie Y; Xu K; Lei W; Zhang C; Han P; Li Y; Jin X; Huan Y; Lu Y; Zhang R; Li X; Zhao X; Xu K; Liao P; Lu X; Bi Y; Song H; Wu G; Zhu B; Gao GF
    Emerg Microbes Infect; 2023 Dec; 12(2):2231573. PubMed ID: 37394992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice.
    Kim E; Khan MS; Ferrari A; Huang S; Sammartino JC; Percivalle E; Kenniston TW; Cassaniti I; Baldanti F; Gambotto A
    Microbiol Spectr; 2023 Jun; 11(3):e0436322. PubMed ID: 37162333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.